Negative Corporate Rating Actions Accumulate Within U.S. BSL CLO Buckets
In May, downgrades amongst U.S. broadly syndicated loan (BSL) collateralized loan obligation (CLO) exposures outpaced upgrades 22 to 15, a recent high since the pandemic (see "U.S. Corporate Rating Actions Tracker 2022 (As Of June 3)," published June 6, 2022). A handful of U.S. BSL CLO obligors experienced downgrades into the 'CCC' category, while others (including Talen Energy, Envision, and Carestream) saw their ratings lowered to non-performing (see table 1). As a result, exposure to issuers with a non-performing rating across the Index has inched up to 20 basis points (bps) at the start of June. Widely-held Envision saw its issuer credit rating raised to 'CCC/Watch negative' from 'SD' on May 16, 2022.
Table 1
U.S. CLO Exposure To Issuers Downgraded Into 'CCC' And Non-performing Category (May 2022) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Rating | ||||||||||||
Action date | Issuer name | GIC | To | From | U.S. BSL cohort as of first-quarter 2022 | |||||||
5/3/2022 | Intrado Corp. | IT services | CCC+/Stable | B-/Negative | Top 250 | |||||||
5/11/2022 | DIEBOLD NIXDORF INC. | Technology hardware, storage, and peripherals | CCC+/Watch negative | B-/Positive | 751 to 1,000 | |||||||
5/12/2022 | pH Beauty Holdings III Inc. | Personal products | CCC+/Negative | B-/Negative | 1,500+ | |||||||
5/25/2022 | Carrols Restaurant Group Inc. | Hotels, restaurants, and leisure | CCC+/Negative | B-/Stable | 1,001 to 1,250 | |||||||
5/26/2022 | TecoStar Holdings Inc. | Health care equipment and supplies | CCC+/Negative | B-/Negative | 251 to 500 | |||||||
5/3/2022 | Carestream Health Inc. | Health care equipment and supplies | CC/Watch negative | B-/Stable | 251 to 500 | |||||||
5/3/2022 | Envision Healthcare Corp. | Health care providers and services | SD | CCC/Watch negative | Top 250 | |||||||
5/10/2022 | Talen Energy Supply LLC | Independent power and renewable electricity producers | D | CCC/Negative | 501 to 750 | |||||||
BSL--Broadly syndicated loan. CLO--Collateralized loan obligation. |
Despite these negative rating actions, we note that CLO 'CCC' asset buckets still remain well below the typical 7.5% threshold for a large majority of transactions in the Index. The recent drop in loan prices, by itself, will likely have a limited impact on CLO junior overcollateralization (O/C) test cushions, for now.
Table 2
CLO BSL Index Metrics (CLO Insights 2022 U.S. BSL Index) | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
As of date | 'B-' (%) | 'CCC' category (%) | Nonperforming category (%) | SPWARF | WARR (%) | Watch negative (%) | Negative outlook (%) | Weighted avg. price of portfolio ($) | Jr. O/C cushion (%) | % of target par | Turnover (%) | SOFR exposure (%)(i) | ||||||||||||||
Jan. 2022 | 26.41 | 4.94 | 0.17 | 2700 | 60.44 | 0.88 | 12.33 | 98.79 | 4.37 | 99.68 | 0.00 | 1.14 | ||||||||||||||
Feb. 2022 | 27.16 | 4.27 | 0.37 | 2708 | 60.43 | 0.28 | 11.94 | 98.83 | 4.41 | 99.68 | 5.68 | 2.77 | ||||||||||||||
March 2022 | 27.09 | 4.26 | 0.39 | 2708 | 60.41 | 0.11 | 11.35 | 98.02 | 4.40 | 99.68 | 8.15 | 6.64 | ||||||||||||||
April 2022 | 27.44 | 4.17 | 0.13 | 2690 | 60.45 | 1.06 | 10.86 | 97.88 | 4.31 | 99.69 | 11.35 | 9.53 | ||||||||||||||
May 2022 | 27.76 | 4.26 | 0.14 | 2700 | 60.45 | 1.20 | 9.83 | 97.57 | 4.30 | 99.70 | 14.46 | 11.55 | ||||||||||||||
June 2022 | 27.70 | 4.14 | 0.20 | 2706 | 60.48 | 1.27 | 10.46 | 94.60 | 4.39 | 99.71 | 16.66 | 12.47 | ||||||||||||||
(i)Based off trustee reports dated within one month prior to being available to us at the start of each month. This index includes only 2021 vintage and prior transactions that have closed with CLO liabilities indexed to LIBOR (excludes 2022 vintage CLOs that would be indexed to SOFR). BSL CLO--Broadly syndicated loan collateralized loan obligation. SPWARF--S&P Global Ratings' weighted average rating factor. WARR--Weighted average recovery rate. O/C--Overcollateralization. SOFR--Secured Overnight Financing Rate. See Appendix section for details about the CLO Insights 2022 U.S. BSL Index. |
CLO Tranche MVOCs Decline While O/C Cushions Remain Stable
Of the trustee reports available to us at the start of June, 'BB' tranche O/C test cushions (the dashed lines in chart 1) remained stable through the second quarter. This contrasts with market value coverage for these same tranches, which fell significantly over the same period. If BSL CLO 'CCC' baskets were significantly exceeding their typical 7.5% allowance, this drop in loan prices could have had a material impact on 'BB' tranche O/C test cushions, but this isn't the case so far.
Chart 1
The drop in loan prices have caused market value O/Cs (the market value of CLO portfolio divided by the cumulative sum of the CLO tranches; MVOCs) to drop notably (the solid lines in chart 1). Some of the junior tranches across the Index now have MVOCs that are below 100% (about 5% of the junior tranches across the Index originally rated within the 'BB' category have MVOCs below 100%; about 40% of the tranches originally rated within the 'B' category have MVOCs below 100%). We note many of the transactions that have lower MVOCs and lower junior O/C cushions are from pre-pandemic CLOs. Given the economic stress these transactions saw in 2020, this cohort entered the year with a lower par balance (relative to their target par balance) and higher 'CCC' and non-performing buckets, which have contributed to the lower O/C cushions and MVOC values this year.
CLOs are not market value structures, and loan prices are not a direct input within our CLO ratings analysis. However, MVOCs below 100% may have implications for amortizing CLOs as it makes optional redemptions through portfolio liquidation at market prices significantly harder. Not being able to optionally redeem an amortizing transaction exposes the junior tranches to future credit deterioration of the CLO obligors that remain in the residual portfolio.
Loan Maturity Wall Is More Pushed Out Among Reinvesting U.S. CLO Obligors
Currently, about 100 S&P Global Ratings-rated U.S. CLOs with about $38 billion in assets under management have exited their reinvesting period and are currently in their amortization phase. Relative to the assets held within reinvesting U.S. BSL CLO portfolios, a higher proportion of the loans held in amortizing CLOs:
- Are from obligors rated 'CCC+' and below (8.0% vs 4.4%);
- Were trading below 90 as of the start of June 2022 (9.7% vs 6.9%); and
- Are maturing in 2025 or sooner.
The maturity wall for the overall corporate loan market is well pushed out after the leveraged loan refinancing wave of 2021 (see chart 2). It isn't currently a significant credit concern, but we did find the gap between the maturity profiles of assets in reinvesting BSL CLO and amortizing CLOs interesting, as it is likely largely a function of CLO vintage.
Chart 2
Appendix: CLO Insights 2022 Index U.S. BSL Index
The CLO Insights 2022 Index U.S. BSL Index (2022 Index) is an index of just over 600 S&P Global Ratings-rated U.S. BSL collateralized loan obligations (CLOs) that had already started issuing trustee reports by the start of 2022 and based on their transaction documents aren't scheduled to exit their reinvestment period during 2022. The 2022 Index includes CLOs across various vintages (including deals that were reset) issued by 121 different CLO managers. The 2022 Index excludes static deals and deals that, based on their transaction documents, we expect to exit their reinvestment period before the end of 2022. We plan to provide monthly updates of key metrics based off this index for the remainder of 2022 (see table 2).
This report does not constitute a rating action.
Primary Credit Analysts: | Daniel Hu, FRM, New York + 1 (212) 438 2206; daniel.hu@spglobal.com |
Stephen A Anderberg, New York + (212) 438-8991; stephen.anderberg@spglobal.com | |
Secondary Contact: | Deegant R Pandya, New York + 1 (212) 438 1289; deegant.pandya@spglobal.com |
No content (including ratings, credit-related analyses and data, valuations, model, software, or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced, or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of Standard & Poor’s Financial Services LLC or its affiliates (collectively, S&P). The Content shall not be used for any unlawful or unauthorized purposes. S&P and any third-party providers, as well as their directors, officers, shareholders, employees, or agents (collectively S&P Parties) do not guarantee the accuracy, completeness, timeliness, or availability of the Content. S&P Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an “as is” basis. S&P PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED, OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.
Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P’s opinions, analyses, and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment, and experience of the user, its management, employees, advisors, and/or clients when making investment and other business decisions. S&P does not act as a fiduciary or an investment advisor except where registered as such. While S&P has obtained information from sources it believes to be reliable, S&P does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives. Rating-related publications may be published for a variety of reasons that are not necessarily dependent on action by rating committees, including, but not limited to, the publication of a periodic update on a credit rating and related analyses.
To the extent that regulatory authorities allow a rating agency to acknowledge in one jurisdiction a rating issued in another jurisdiction for certain regulatory purposes, S&P reserves the right to assign, withdraw, or suspend such acknowledgement at any time and in its sole discretion. S&P Parties disclaim any duty whatsoever arising out of the assignment, withdrawal, or suspension of an acknowledgment as well as any liability for any damage alleged to have been suffered on account thereof.
S&P keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain business units of S&P may have information that is not available to other S&P business units. S&P has established policies and procedures to maintain the confidentiality of certain nonpublic information received in connection with each analytical process.
S&P may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P reserves the right to disseminate its opinions and analyses. S&P's public ratings and analyses are made available on its Web sites, www.spglobal.com/ratings (free of charge), and www.ratingsdirect.com (subscription), and may be distributed through other means, including via S&P publications and third-party redistributors. Additional information about our ratings fees is available at www.spglobal.com/usratingsfees.